Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir
暂无分享，去创建一个
C. Tremblay | B. Brenner | D. Rouleau | J. Routy | Réjean Thomas | M. Robbins | T. Mesplède | R. Lalonde | J. Baril | P. Cote | Maureen Oliveira | C. Fortin | M. Potter | A. de Pokomandy | N. Gilmore | Ruxandra-Ilinca Ibanescu | B. Trottier | C. Milne | R. Leblanc | B. Lessard | Kaitlin Anstett | S. Vézina | J. Szabo | E. Huchet | L. Charest | S. Dufresne | M. Klein | M. Charron | M. Munoz | Mario Jean-Guy Louise Marc-André Pierre Alexandra Serge Legault Baril Charest Charron Côté de Pokom | Mario Legault | Jason Friedman | Louise Labreque | Jason Friedman | Louise Labreque